Oaktree Acquisition III Life Sciences Corp（OACC）股票分析

AI 分析 of Oaktree Acquisition III Life Sciences Corp (OACC)

持有

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.

估值指標

Oaktree Acquisition III Life Sciences Corp（OACC）目前預期本益比為 0.00，5 年平均預期本益比為 0.00。

預期本益比

嚴重低估

5 年均值 P/E

0.00

目前P/E

0.00

高估

0.00

低估

0.00

預期 EV/EBITDA

嚴重低估

5 年均值 EV/EBITDA

0.00

目前EV/EBITDA

0.00

高估

0.00

低估

0.00

預期股價營收比

合理

5 年均值 P/S

0.06

目前P/S

0.00

高估

0.84

低估

-0.72

Alphio AI 對 OACC 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重（25 / 50 / 25），不構成保證。

樂

樂觀

樂觀 · 25%OACC

$12.28

情境價格

基

基準

基準 · 50%OACC

$11.50

情境價格

悲

悲觀

悲觀 · 25%OACC

$10.82

情境價格

持有 OACC 的大戶

E

Empyrean Capital Partners, LP

+ 持有OACC

-3.81%

3個月報酬率

OACC 常見問題 —— 由 Alphio AI 解答

Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues. It operates in the Financials sector.

Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.